Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosionin vitro

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts

(2014) Natasja Nielsen et al.   IMMUNOLOGY

Cells of the Immune System Orchestrate Changes in Bone Cell Function

(2013) Sarah E. Wythe et al.   CALCIFIED TISSUE INTERNATIONAL

Vitamin D Receptor in Osteoblasts Is a Negative Regulator of Bone Mass Control

(2013) Yoko Yamamoto et al.   ENDOCRINOLOGY

Effect of IL-15 and Natural Killer Cells on Osteoclasts and Osteoblasts in a Mouse Coculture

(2013) Hiroaki Takeda et al.   INFLAMMATION

Natural killer cells in human autoimmune disorders

(2013) Leslie A Fogel et al.   ARTHRITIS RESEARCH & THERAPY

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ

(2012) Dhifaf Sarhan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A

(2012) Natasja Nielsen et al.   PLoS One

Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis

(2011) Isidoro González-Álvaro et al.   PLoS One

Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis

(2010) K. Soderstrom et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human natural killer cells

(2008) M. A. Caligiuri   BLOOD

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-  and IL-17

(2008) M. Hashizume et al.   RHEUMATOLOGY